170 related articles for article (PubMed ID: 2894935)
1. Somatostatin in the idiopathic inflammatory bowel diseases.
Koch TR; Carney JA; Morris VA; Go VL
Dis Colon Rectum; 1988 Mar; 31(3):198-203. PubMed ID: 2894935
[TBL] [Abstract][Full Text] [Related]
2. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
Koch TR; Michener SR; Carney JA; Go VL
Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
[TBL] [Abstract][Full Text] [Related]
3. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
Koch TR; Carney JA; Go VL
Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
[TBL] [Abstract][Full Text] [Related]
4. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
5. Beta2 integrin/ICAM expression in Crohn's disease.
Bernstein CN; Sargent M; Gallatin WM
Clin Immunol Immunopathol; 1998 Feb; 86(2):147-60. PubMed ID: 9473377
[TBL] [Abstract][Full Text] [Related]
6. Distribution and quantification of somatostatin in inflammatory disease.
Watanabe T; Kubota Y; Sawada T; Muto T
Dis Colon Rectum; 1992 May; 35(5):488-94. PubMed ID: 1348980
[TBL] [Abstract][Full Text] [Related]
7. Peptide YY concentrations in normal ileum and colon and in idiopathic inflammatory bowel disease.
Koch TR; Roddy DR; Carney JA; Go VL
Dig Dis Sci; 1988 Oct; 33(10):1322-8. PubMed ID: 3168701
[TBL] [Abstract][Full Text] [Related]
8. Mucosal metabolism in ulcerative colitis and Crohn's disease.
Duffy MM; Regan MC; Ravichandran P; O'Keane C; Harrington MG; Fitzpatrick JM; O'Connell PR
Dis Colon Rectum; 1998 Nov; 41(11):1399-405. PubMed ID: 9823806
[TBL] [Abstract][Full Text] [Related]
9. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy.
Calam J; Ghatei MA; Domin J; Adrian TE; Myszor M; Gupta S; Tait C; Bloom SR
Dig Dis Sci; 1989 Aug; 34(8):1193-8. PubMed ID: 2568900
[TBL] [Abstract][Full Text] [Related]
12. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
13. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
Rachmilewitz D; Stamler JS; Bachwich D; Karmeli F; Ackerman Z; Podolsky DK
Gut; 1995 May; 36(5):718-23. PubMed ID: 7541008
[TBL] [Abstract][Full Text] [Related]
14. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.
Murch SH; Braegger CP; Sessa WC; MacDonald TT
Lancet; 1992 Feb; 339(8790):381-5. PubMed ID: 1346658
[TBL] [Abstract][Full Text] [Related]
15. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases.
Schauber J; Rieger D; Weiler F; Wehkamp J; Eck M; Fellermann K; Scheppach W; Gallo RL; Stange EF
Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):615-21. PubMed ID: 16702850
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Fas-Ligand in Inflammatory Bowel Diseases and in Acute Appendicitis.
Kokkonen TS; Karttunen TJ
J Histochem Cytochem; 2015 Dec; 63(12):931-42. PubMed ID: 26374830
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.
Brown M; Hughes KR; Moossavi S; Robins A; Mahida YR
Clin Exp Immunol; 2014 Oct; 178(1):28-39. PubMed ID: 24828022
[TBL] [Abstract][Full Text] [Related]
19. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
Adar T; Shteingart S; Ben-Ya'acov A; Shitrit AB; Livovsky DM; Shmorak S; Mahamid M; Melamud B; Vernea F; Goldin E
Dig Dis Sci; 2016 Jul; 61(7):1915-24. PubMed ID: 26874691
[TBL] [Abstract][Full Text] [Related]
20. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
Babyatsky MW; Rossiter G; Podolsky DK
Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
